Actissist: Proof-of-concept trial of a theory-driven digital intervention for psychosis.

Sandra Bucci, Christine Barrowclough, John Ainsworth, Matthew Machin, Rohan Morris, Katherine Berry, Richard Emsley, Shon Lewis, Dawn Edge, Iain Buchan, Gillian Haddock

Research output: Contribution to journalArticlepeer-review


Timely access to intervention for psychosis is crucial yet problematic. As such, health care providers are forming digital strategies for addressing mental health challenges. A theory-driven digital intervention that monitors distressing experiences and provides real-time active management strategies could improve the speed and quality of recovery in psychosis, over and above conventional treatments. This study assesses the feasibility and acceptability of Actissist, a digital health intervention grounded in the cognitive model of psychosis that targets key early psychosis domains.

A proof-of-concept, single, blind, randomized controlled trial of Actissist, compared to a symptom-monitoring control. Thirty-six early psychosis patients were randomized on a 2:1 ratio to each arm of the trial. Actissist was delivered via a smartphone app over 12-weeks; clinical and functional assessment time-points were baseline, post-treatment and 22-weeks. Assessors’ blind to treatment condition conducted the assessments. Acceptability was examined using qualitative methods.

Actissist was feasible (75% participants used Actissist at least once/day; uptake was high, 97% participants remained in the trial; high follow-up rates), acceptable (90% participants recommend Actissist), and safe (0 serious adverse events), with high levels of user satisfaction. Treatment effects were large on negative symptoms, general psychotic symptoms and mood. The addition of Actissist conferred benefit at post-treatment assessment over routine symptom-monitoring and treatment as usual.

This is the first controlled proof-of-concept trial of a theory-driven digital health intervention for early psychosis. Actissist is feasible and acceptable to early psychosis patients, with a strong signal for treatment efficacy.
Original languageEnglish
Pages (from-to)1070-1080
JournalSchizophrenia Bulletin
Issue number5
Early online date20 Aug 2018
Publication statusPublished - Sept 2018


  • psychosis
  • Digital health
  • mHealth
  • Early psychosis
  • Randomised controlled trial

Research Beacons, Institutes and Platforms

  • Manchester Institute for Collaborative Research on Ageing


Dive into the research topics of 'Actissist: Proof-of-concept trial of a theory-driven digital intervention for psychosis.'. Together they form a unique fingerprint.

Cite this